We are live on ! Find out more
BPC

Banque Pictet & Cie Portfolio holdings

AUM $16B
1-Year Est. Return 29.1%
This Fund
S&P 500
This Quarter Est. Return
+11.49%
1 Year Est. Return
+29.1%
3 Year Est. Return
+74.82%
5 Year Est. Return
+105.76%
10 Year Est. Return
+488.78%
AUM
$12.1B
AUM Growth
+$3.61B
Cap. Flow
+$2.52B
Cap. Flow %
20.87%
Top 10 Hldgs %
58.14%
Holding
482
New
48
Increased
86
Reduced
174
Closed
135

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$175M
2
V icon
Visa
V
+$20.4M
3
ELV icon
Elevance Health
ELV
+$7.71M
4
NFLX icon
Netflix
NFLX
+$4.65M
5
PM icon
Philip Morris
PM
+$4.25M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.15%
2 Healthcare 13.82%
3 Technology 11.04%
4 Communication Services 9.62%
5 Consumer Staples 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
151
Netflix
NFLX
$311B
$5.19M 0.04%
+106,500
New +$4.65M
ETN icon
152
Eaton
ETN
$178B
$5.13M 0.04%
21,300
WST icon
153
West Pharmaceutical
WST
$24.7B
$5.09M 0.04%
14,460
+994
+7% +$352K
GB
154
DELISTED
Global Blue Group Holding
GB
$5.07M 0.04%
1,071,429
+128,571
+14% +$645K
BMY icon
155
Bristol-Myers Squibb
BMY
$130B
$5M 0.04%
97,367
+56,157
+136% +$2.95M
THC icon
156
Tenet Healthcare
THC
$20.9B
$4.9M 0.04%
64,821
-7,839
-11% -$497K
WMT icon
157
Walmart Inc
WMT
$901B
$4.82M 0.04%
91,815
+18,465
+25% +$977K
IRTC icon
158
iRhythm Holdings
IRTC
$4.02B
$4.72M 0.04%
44,088
+6,993
+19% +$609K
TXG icon
159
10x Genomics
TXG
$7.62B
$4.55M 0.04%
81,312
-9,127
-10% -$397K
FCX icon
160
Freeport-McMoran
FCX
$96.4B
$4.47M 0.04%
105,110
-12,000
-10% -$443K
ALNY icon
161
Alnylam Pharmaceuticals
ALNY
$29.6B
$4.37M 0.04%
22,829
-2,595
-10% -$442K
ALGN icon
162
Align Technology
ALGN
$12.3B
$4.29M 0.04%
15,668
-4,074
-21% -$966K
IVV icon
163
iShares Core S&P 500 ETF
IVV
$902B
$4.2M 0.03%
8,787
-353
-4% -$158K
GMED icon
164
Globus Medical
GMED
$11.4B
$4.18M 0.03%
78,353
-8,206
-9% -$400K
HES
165
DELISTED
Hess
HES
$4.02M 0.03%
27,900
-7,000
-20% -$1.03M
CSTL icon
166
Castle Biosciences
CSTL
$985M
$3.94M 0.03%
182,664
-20,611
-10% -$363K
DIS icon
167
Walt Disney
DIS
$179B
$3.88M 0.03%
42,960
+379
+0.9% +$33.4K
WM icon
168
Waste Management
WM
$90.7B
$3.87M 0.03%
21,600
IBN icon
169
ICICI Bank
IBN
$107B
$3.86M 0.03%
161,726
+124,663
+336% +$2.87M
ARVN icon
170
Arvinas
ARVN
$588M
$3.83M 0.03%
+92,933
New +$2.17M
EMR icon
171
Emerson Electric
EMR
$91.7B
$3.83M 0.03%
39,300
GLD icon
172
SPDR Gold Trust
GLD
$143B
$3.8M 0.03%
19,862
-14,368
-42% -$2.63M
URTH icon
173
iShares MSCI World ETF
URTH
$8.32B
$3.73M 0.03%
28,025
-880
-3% -$110K
ARWR icon
174
Arrowhead Research
ARWR
$12.6B
$3.62M 0.03%
118,313
-13,386
-10% -$355K
MTCH icon
175
Match Group
MTCH
$8.45B
$3.57M 0.03%
97,855
+8,451
+9% +$285K

Similar funds

Banque Pictet & Cie's Q4 2023 Portfolio in Review

As of Q4 2023, Banque Pictet & Cie held 482 positions worth $12.1B, up 43% from $8.47B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Banque Pictet & Cie deployed $2.52B of net new capital in Q4 2023, opening 48 new positions and adding to 86 existing holdings. Its largest new stake was Netflix: 106,500 shares worth $5.19M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Microsoft, an estimated $48M trimmed.

  • Banque Pictet & Cie's largest Q4 2023 buy was Netflix: 106,500 shares worth $5.19M.
  • Banque Pictet & Cie added most to Texas Instruments in Q4 2023, an estimated $175M increase.
  • Banque Pictet & Cie's biggest Q4 2023 reduction was Microsoft, cutting an estimated $48M.
  • Banque Pictet & Cie fully exited Waters Corp in Q4 2023, selling an estimated $7.3M.
  • Banque Pictet & Cie's ten largest holdings make up 58% of its $12.1B portfolio in Q4 2023.
  • Banque Pictet & Cie opened 48 new positions and closed 135 in Q4 2023.
  • Banque Pictet & Cie's portfolio value rose 43% quarter-over-quarter to $12.1B.

Based on Banque Pictet & Cie's 13F filing for Q4 2023, filed 9 Feb 2024.